Leptin signaling and obesity: cardiovascular consequences - PubMed (original) (raw)
Review
Leptin signaling and obesity: cardiovascular consequences
Ronghua Yang et al. Circ Res. 2007.
Abstract
Leptin, among the best known hormone markers for obesity, exerts pleiotropic actions on multiple organ systems. In this review, we summarize major leptin signaling pathways, namely Janus-activated kinase/signal transducers and activators of transcription and mitogen-activated protein kinase, including possible mechanisms of leptin resistance in obesity. The effects of leptin on the cardiovascular system are discussed in detail, including its contributions to hypertension, atherosclerosis, depressed myocardial contractile function, fatty acid metabolism, hypertrophic remodeling, and reduction of ischemic/reperfusion injury. The overall goal is to summarize current understanding of how altered leptin signaling in obesity contributes to obesity-related cardiovascular disease.
Similar articles
- Leptin and cardiovascular diseases.
Hou N, Luo JD. Hou N, et al. Clin Exp Pharmacol Physiol. 2011 Dec;38(12):905-13. doi: 10.1111/j.1440-1681.2011.05619.x. Clin Exp Pharmacol Physiol. 2011. PMID: 21957899 Review. - Leptin and the clinical cardiovascular risk.
Singh M, Bedi US, Singh PP, Arora R, Khosla S. Singh M, et al. Int J Cardiol. 2010 Apr 30;140(3):266-71. doi: 10.1016/j.ijcard.2009.07.019. Epub 2009 Nov 27. Int J Cardiol. 2010. PMID: 19944469 Review. - Leptin and cardiovascular diseases.
Luo JD, Zhang GS, Chen MS. Luo JD, et al. Drug News Perspect. 2005 Sep;18(7):427-31. doi: 10.1358/dnp.2005.18.7.939346. Drug News Perspect. 2005. PMID: 16362081 Review. - [Arterial hypertension and obesity--a dangerous combination].
Zakharieva S. Zakharieva S. Vutr Boles. 1999;31(1):28-32. Vutr Boles. 1999. PMID: 10847146 Review. Bulgarian. - Obesity hypertension: the emerging role of leptin in renal and cardiovascular dyshomeostasis.
Kshatriya S, Reams GP, Spear RM, Freeman RH, Dietz JR, Villarreal D. Kshatriya S, et al. Curr Opin Nephrol Hypertens. 2010 Jan;19(1):72-8. doi: 10.1097/MNH.0b013e328332fb49. Curr Opin Nephrol Hypertens. 2010. PMID: 19851106 Review.
Cited by
- Leptin Promotes Greater Ki67 Expression in CD4+ T Cells From Obese Compared to Lean Persons Living With HIV.
Fuseini H, Smith R, Nochowicz CH, Simmons JD, Hannah L, Wanjalla CN, Gabriel CL, Mashayekhi M, Bailin SS, Castilho JL, Hasty AH, Koethe JR, Kalams SA. Fuseini H, et al. Front Immunol. 2022 Jan 17;12:796898. doi: 10.3389/fimmu.2021.796898. eCollection 2021. Front Immunol. 2022. PMID: 35111163 Free PMC article. - Leptin Concentrations in Non-Obese and Obese Non-Diabetes Nigerian-Africans.
Agbogu-Ike OU, Ogoina D, Onyemelukwe GC. Agbogu-Ike OU, et al. Diabetes Metab Syndr Obes. 2021 Dec 21;14:4889-4902. doi: 10.2147/DMSO.S264735. eCollection 2021. Diabetes Metab Syndr Obes. 2021. PMID: 34992397 Free PMC article. - Exercise induced adipokine changes and the metabolic syndrome.
Golbidi S, Laher I. Golbidi S, et al. J Diabetes Res. 2014;2014:726861. doi: 10.1155/2014/726861. Epub 2014 Jan 19. J Diabetes Res. 2014. PMID: 24563869 Free PMC article. Review. - Secondary hypertension: obesity and the metabolic syndrome.
Singer GM, Setaro JF. Singer GM, et al. J Clin Hypertens (Greenwich). 2008 Jul;10(7):567-74. doi: 10.1111/j.1751-7176.2008.08178.x. J Clin Hypertens (Greenwich). 2008. PMID: 18607142 Free PMC article. Review. - Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis.
Rho YH, Solus J, Sokka T, Oeser A, Chung CP, Gebretsadik T, Shintani A, Pincus T, Stein CM. Rho YH, et al. Arthritis Rheum. 2009 Jul;60(7):1906-14. doi: 10.1002/art.24626. Arthritis Rheum. 2009. PMID: 19565493 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical